Effect of home environment control on children with atopic or non-atopic asthma

Allergology International

Volumn 55, Issue 2, 2006, Pages 141-148

  Nishioka, Kenji ^a   Saito, Akemi ^a   Akiyama, Kazuo ^a   Yasueda, Hiroshi ^a  

^a SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Asthma; Der f 1; Der p 1; Environment control; House dust mites

Indexed keywords

ALLERGEN; CLENBUTEROL; IMMUNOGLOBULIN E ANTIBODY; PROCATEROL; THEOPHYLLINE;

ALLERGIC ASTHMA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COUNSELING; DERMATOPHAGOIDES; FEMALE; HOME ENVIRONMENT; HUMAN; INFORMED CONSENT; MALE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; THEOPHYLLINE BLOOD LEVEL;

EID: 33745649363     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.141     Document Type: Article

References (26)

1. Pollart SM, Chapman MD, Fiocco GP, Rose G, Platts-Mills TAE. Epidemiology of acute asthma: IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J. Allergy Clin. Immunol. 1989;83:875-882.
2. Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms, I: epidemiology. Clin. Exp. Allegy 1992;22:325-336.
3. Martinez FD, Cline M, Burrows B. Increased incidence of asthma in children of smoking mothers. Pediatrics 1992; 89:21-26.
4. Duff AL, Pomeranz ES, Gelber LE et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993;92:535-540.
5. Platts-Mills TAE, Vervloet D, Thomas WR, Aalberse RC, Chapman MD. Indoor allergens and asthma: report of the third international workshop. J. Allergy Clin. Immunol. 1997;100:1(1)S1-24.
6. Sarsfield JK, Gowland G, Toy R, Norman ALE. Mite sensitive asthma of childhood. Trial of avoidance measures. Arch. Dis. Child 1974;49:716-721.
7. Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J. Allergy Clin. Immunol. 1992; 90:135-138.
8. Murray AB, Ferguson AC. Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: A controlled trial. Pediatrics 1983;71: 418-422.
9. Burr ML, Dean BV, Merett TG et al. Effects of anti-mite measures on children with mite sensitive asthma: a controlled clinical trial. Thorax 1980;35:506-512.
10. Gotzsche PC, Hammarquist C, Burr M. House dust mite control measures in the management of asthma: meta-analysis. BMJ 1998;317:1105-1110.
11. Bruno G, Milita O, Ferrara M, Nisini R, Cantani A, Businco L. Prevention of atopic diseases in high risk babies (long-term follow-up). Allergy Proc. 1993;14:181-186.
12. Hide DW, Matthews S, Matthews L et al. Effect of allergen avoidance in infancy on allergic manifestations at age two years. J. Allergy Clin. Immunol. 1994;93:842-846.
13. Yasueda H, Saito A, Akiyama K et al. Estimation of Der p and Der f I quantities in the reference preparations of dust mite extracts. Clin. Exp. Allergy 1994;24:1030-1035.
14. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. National Asthma Education Program Expert Panel Report Guidelines for the Diagnosis and Management of Asthma, publication no. 91-3042:Bethesda: National Institute of Health, 1991.
15. Sakaguchi M, Inoue S, Yasueda H, Irie T, Yoshizawa S, Shida T. Measurement of allergens associated with dust mite allergy. II. Concentrations of airborne mite allergens (Der I and Der II) in the house. Int. Arch. Allergy Appl. Immunol. 1989;90:190-193.
16. Nishioka K, Yasueda H, Saito H. Preventive effect of bedding encasement with microfine fibers on mite sensitization. J. Allergy Clin. Immunol. 1998;101:28-32.
17. Doull IJ, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997;315:858-862.
18. Platts-Mills TAE, Thomas WR, Aalberse RC, Vervloet D, Chapman MD. Dust mite allergens and asthma: report of a 2nd international workshop. J. Allergy Clin. Immunol. 1992;89:1046-1060.
19. Mori A, Suko M, Kaminuma O et al. A critical role of IL-2 for the production and gene transcription of IL-5 in allergen-specific human T cell clones. Int. Immunol. 1996; 8:1889-1895.
20. Schulz O, Sewell HF, Shakib F. Proteolytic cleavage of CD25, the a subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J. Exp. Med. 1998;187:271-275.
21. Comoy EE, Pestel J, Duez C et al. The house dust mite allergen, dermatophagoides pteronyssinus, promotes type 2 responses by modulating the balance between IL-4 and IFN-γ. J Immunol. 1998;160:2456-2462.
22. Akaike T, Maeda H, Maruo K, Sakata Y, Sato K. Potentiation of infectivity and pathogenesis of influenza A virus by a house dust mite protease. J. Infect. Dis. 1994;170:1023-1026.
23. Woodcock A, Forster L, Matthews E et al. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N. Engl. J. Med. 2003;349: 225-236.
24. Rijssenbeek-Nouwens L, Costing AJ, de Bruin-Weller MS et al. Clinical evaluation of the effect of anti-allergic mattress covers in patients with moderate to severe asthma and house dust mite allergy: a randomized double blind placebo controlled study. Thorax 2002;57:784-790.
25. Morgan WJ, Crain EF, Gruchalla RS et al. Results of a home-based environmental intervention among urban children with asthma. N. Engl. J. Med. 2004;351:1068-1080.
26. HalkenS, Host A, Niklassen U et al. Effect of mattress and pillow encasings on children with asthma and house dust mite allergy. J. Allergy Clin. Immunol. 2003;111:169-176.